Wordt geladen...
Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study
Neprilysin (NEP) is a neutral endopeptidase with diverse physiological roles in the body. NEP's role in degradation of diverse classes of peptides such as amyloid beta, natriuretic peptide, substance P, angiotensin, endothelins, etc., is associated with pathologies of alzheimer's, kidney a...
Bewaard in:
| Gepubliceerd in: | J Mol Struct |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier B.V.
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7422802/ https://ncbi.nlm.nih.gov/pubmed/32834116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molstruc.2020.129073 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|